$116.95
0.140.12%
At Close: -
$116.95
00.00%
After Hours: 5:03 PM EDT
15 minutes delayed
Comments
Loading...
Blueprint Medicines
BPMCNASDAQ
Blueprint Medicines (NASDAQ:BPMC) Stock, Earnings Estimates, EPS, And Revenue
Blueprint Medicines reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 1
EPS Estimate
$-1.290
Quarterly Revenue Estimate
$103M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$282.2M
Analyze the earnings history of Blueprint Medicines using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BPMC | Blueprint Medicines | -$2.20 | — | — | — | $56.57M | — | — | — | 10/24/2024 | Get Alert |
| BPMC | Blueprint Medicines | -$2.19 | -$1.29 | — | — | $57.57M | $103.00M | — | — | 08/01/2024 | Get Alert |
| BPMC | Blueprint Medicines | -$2.15 | -$1.66 | -$1.32 | 20.48% | $63.29M | $80.43M | $96.12M | 19.50% | 05/02/2024 | Get Alert |
| BPMC | Blueprint Medicines | -$2.65 | -$2.04 | -$1.82 | 10.78% | $38.78M | $66.64M | $71.96M | 7.98% | 02/15/2024 | Get Alert |
| BPMC | Blueprint Medicines | -$2.23 | -$2.37 | -$2.20 | 7.17% | $65.98M | $50.40M | $56.57M | 12.23% | 10/26/2023 | Get Alert |
| BPMC | Blueprint Medicines | -$2.68 | -$2.58 | -$2.19 | 15.12% | $36.55M | $45.00M | $57.57M | 27.93% | 08/02/2023 | Get Alert |
| BPMC | Blueprint Medicines | -$1.79 | -$2.67 | -$2.15 | 19.48% | $62.73M | $41.96M | $63.29M | 50.83% | 05/04/2023 | Get Alert |
| BPMC | Blueprint Medicines | -$0.99 | -$2.65 | -$2.65 | 0.00% | $107.02M | $34.43M | $38.78M | 12.64% | 02/16/2023 | Get Alert |
| BPMC | Blueprint Medicines | -$2.00 | -$2.49 | -$2.23 | 10.44% | $24.19M | $43.37M | $65.98M | 52.13% | 11/01/2022 | Get Alert |
| BPMC | Blueprint Medicines | -$1.86 | -$2.23 | -$2.68 | -20.18% | $27.30M | $37.24M | $36.55M | -1.86% | 08/02/2022 | Get Alert |
| BPMC | Blueprint Medicines | -$1.72 | -$1.94 | -$1.79 | 7.73% | $21.58M | $36.65M | $62.73M | 71.16% | 05/03/2022 | Get Alert |
| BPMC | Blueprint Medicines | -$1.53 | -$1.65 | -$0.99 | 40.00% | $34.11M | $102.69M | $107.02M | 4.22% | 02/16/2022 | Get Alert |
| BPMC | Blueprint Medicines | $11.16 | -$1.63 | -$2.00 | -22.70% | $745.12M | $42.47M | $24.19M | -43.05% | 10/28/2021 | Get Alert |
| BPMC | Blueprint Medicines | -$2.28 | -$1.86 | -$1.86 | 0.00% | $8.34M | $19.01M | $27.30M | 43.58% | 07/29/2021 | Get Alert |
| BPMC | Blueprint Medicines | -$2.11 | -$1.86 | -$1.72 | 7.53% | $6.17M | $17.25M | $21.58M | 25.08% | 04/29/2021 | Get Alert |
| BPMC | Blueprint Medicines | -$1.35 | -$1.62 | -$1.53 | 5.56% | $51.53M | $29.24M | $34.11M | 16.65% | 02/17/2021 | Get Alert |
| BPMC | Blueprint Medicines | -$1.93 | $7.72 | $11.16 | 44.56% | $9.14M | $631.57M | $745.12M | 17.98% | 10/29/2020 | Get Alert |
| BPMC | Blueprint Medicines | -$2.04 | -$2.14 | -$2.28 | -6.54% | $5.11M | $6.60M | $8.34M | 26.41% | 07/30/2020 | Get Alert |
| BPMC | Blueprint Medicines | -$1.98 | -$2.17 | -$2.11 | 2.76% | $730.00K | $5.44M | $6.17M | 13.36% | 05/06/2020 | Get Alert |
| BPMC | Blueprint Medicines | -$1.83 | -$1.69 | -$1.35 | — | $1.03M | $26.07M | $51.53M | 97.67% | 02/13/2020 | Get Alert |
| BPMC | Blueprint Medicines | -$1.66 | -$2.17 | -$1.93 | 11.06% | $1.09M | $2.59M | $9.14M | 252.86% | 11/05/2019 | Get Alert |
| BPMC | Blueprint Medicines | -$0.62 | -$1.91 | -$2.04 | -6.81% | $41.44M | $1.98M | $5.11M | 158.08% | 08/01/2019 | Get Alert |
Blueprint Medicines (BPMC) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-02 | $-1.32 | $-1.66 | 20.5 % |
| Dec 2023 | 2024-02-15 | $-1.82 | $-2.04 | 10.8 % |
| Sep 2023 | 2023-10-26 | $-2.20 | $-2.37 | 7.17 % |
| Jun 2023 | 2023-08-02 | $-2.19 | $-2.58 | 15.1 % |
Blueprint Medicines (BPMC) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-02 | $96.12M | $80.43M | 19.5 % |
| Dec 2023 | 2024-02-15 | $71.96M | $66.64M | 7.98 % |
| Sep 2023 | 2023-10-26 | $56.57M | $50.40M | 12.2 % |
| Jun 2023 | 2023-08-02 | $57.57M | $45.00M | 27.9 % |
FAQ
When is Blueprint Medicines (NASDAQ:BPMC) reporting earnings?
Blueprint Medicines (BPMC) is scheduled to report earnings on October 24, 2024. The last reported earnings were for reported on May 2, 2024 for Q1.
What were the latest earnings per share (EPS) for Blueprint Medicines (NASDAQ:BPMC)?
The Actual EPS was $-1.32, which beat the estimate of $-1.66.
What were Blueprint Medicines’s (NASDAQ:BPMC) revenues?
The Actual Revenue was $96.1M, which beat the estimate of $80.4M.
Browse earnings estimates, EPS, and revenue on all stocks.